top
GLIOBLASTOMA NEWSLETTER
Volume 2, Number 9 - 24 April 2003

Volume 2
Archive


Contents


Diagnosis & Evaluation
Integrative Medicine
Overall Management
Psychosocial Aspects
Treatment

Diagnosis & Evaluation


Pirotte B, Goldman S, Salzberg S, Wikler D, David P, Vandesteene A, Van Bogaert P, Salmon I, Brotchi J, Levivier M
Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases
Pediatr Neurosurg 2003 Mar;38(3):146-55

Principi M, Italiani M, Guiducci A, Aprile I, Muti M, Giulianelli G, Ottaviano P
Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas
Neuroradiology 2003 Apr;45(4):205-11


Integrative Medicine


Harris JE.
Interaction of dietary factors with oral anticoagulants: review and applications
J Am Diet Assoc 1995 May;95(5):580-4 

Kaul R, Mishra BK, Sutradar P, Choudhary V, Gujral MS
The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial
Indian J Cancer 1999 Jun-Dec;36(2-4):141-8 

Kelly GS
Rhodiola rosea: a possible plant adaptogen
Altern Med Rev 2001 Jun;6(3):293-302

Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H
Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty
Phytomedicine 2000 Oct;7(5):365-71

Lamson DW, Brignall MS
Antioxidants and cancer therapy II: quick reference guide
Altern Med Rev 2000 Apr;5(2):152-63


Lamson DW, Brignall MS
Antioxidants in cancer therapy; their actions and interactions with oncologic therapies
Altern Med Rev 1999 Oct;4(5):304-29

Vieth R, Chan PC, MacFarlane GD
Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level
Am J Clin Nutr 2001 Feb;73(2):288-94 

Vieth R
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
Am J Clin Nutr 1999 May;69(5):842-56


Overall Management


Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, DiMeco F, Clatterbuck RE, Olivi A, Guarnieri M
New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery
J Neurooncol 2002 Nov;60(2):151-8 


Psychosocial Aspects


Silvestri GA, Knittig S, Zoller JS, Nietert PJ
Importance of faith on medical decisions regarding cancer care
J Clin Oncol 2003 Apr 1;21(7):1379-82 


Treatment


Balana C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, Sarries C, Mendez P, Sanchez JJ, Rosell R
O(6)-methyl-guanine-DNA methyltransferase Methylation in Serum and Tumor DNA Predicts Response to 1,3-Bis(2-Chloroethyl)-1-Nitrosourea but not to Temozolamide Plus Cisplatin in Glioblastoma Multiforme
Clin Cancer Res 2003 Apr;9(4):1461-8 

Beith J., Cook R., Robinson B., Levi J., Bell D., Wheeler H. 
Modulation of resistance to BCNU by depleting MGMT activity with procarbazine in patients with relapsed high-grade gliomas

ASCO Proceedings, 1997 Annual Meeting, Abstract No. 1375

Dolan ME, Pegg AE
O6-benzylguanine and its role in chemotherapy
Clin Cancer Res 1997 Jun;3(6):837-47

bottom


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP